Streetbeat News

Price Targets

PHIO

HC Wainwright & Co. analyst Vernon Bernardino maintains a Buy rating on Phio Pharma (NASDAQ:PHIO) but lowers the price target from $6 to $4.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 11:42 am

PYCR

BTIG analyst Matt VanVliet initiates coverage on Paycor HCM (NASDAQ:PYCR) with a Buy rating and sets a price target of $26.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 11:39 am

PCTY

BTIG analyst Matt VanVliet initiates coverage on Paylocity Holding (PCTY) with a Buy rating and sets a price target of $200.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 11:33 am

FLYW

Deutsche Bank analyst Nate Svensson has initiated coverage on Flywire (NASDAQ:FLYW) with a Buy rating and set a price target of $27.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 11:30 am

BMY

Redburn Atlantic analyst Steve Chesney downgraded Bristol-Myers Squibb (BMY) from Buy to Neutral and reduced the price target from $77 to $54, indicating a more cautious outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 11:27 am

CTLT

RBC Capital analyst Sean Dodge downgraded Catalent (NYSE:CTLT) from Outperform to Sector Perform while raising the price target from $58 to $63.5.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 11:17 am

CMS

Barclays analyst Eric Beaumont has maintained an Equal-Weight rating on CMS Energy (NYSE:CMS) and lowered the price target from $59 to $57.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 11:16 am

ERJ

HSBC analyst Cenk Orcan downgraded Embraer (NYSE:ERJ) from Buy to Hold while raising the price target from $18 to $19.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 11:12 am

CHD

Barclays analyst Lauren Lieberman maintains an Underweight rating on Church & Dwight Co (CHD) and raises the price target from $76 to $80.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 11:11 am

CTLT

UBS analyst John Sourbeer downgraded Catalent (NYSE:CTLT) from Buy to Neutral but raised the price target from $58 to $63.5.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 11:06 am